Baltimore, MD, United States of America

Brian Gregory Murphy



 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Brian Gregory Murphy: Innovator in Medication Delivery Systems

Introduction

Brian Gregory Murphy, an accomplished inventor based in Baltimore, MD, is recognized for his contribution to the field of medication delivery devices. With a patent to his name, he has shown a commitment to improving healthcare through innovative technologies.

Latest Patents

Brian Murphy holds a patent for a medication delivery device that features a dose detection system. This system is designed to enhance the functionality of medication delivery devices by incorporating a dose setting member that rotates relative to an actuator during dose delivery. The device includes a module that can be removably attached to the delivery device, which hosts a dosing component linked to the actuator. A light source and light sensor are part of this dosing component, with a sensed element attached to the dose setting member featuring detectable surface features for accurate dose measurement.

Career Highlights

Currently, Brian Murphy works at Eli Lilly and Company, a prominent player in the pharmaceutical industry, where he continues to develop and refine medical technologies. His dedication to innovation is evident in his work and contributions to the advancement of medication delivery systems.

Collaborations

Throughout his career, Brian has collaborated with notable coworkers, including Roy Howard Byerly and Collin Hunter Grimes. These partnerships have facilitated a creative environment that fosters the development of new ideas and technologies in the medical field.

Conclusion

Brian Gregory Murphy stands out as a key figure in the realm of inventors focused on healthcare solutions. His innovative patent for a medication delivery device reflects his commitment to improving patient care and demonstrates the potential of combining technology with medicine. As he continues to work with his colleagues at Eli Lilly and Company, his contributions to the field will undoubtedly have lasting impacts.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…